Tags

Type your tag names separated by a space and hit enter

Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
Travel Med Infect Dis. 2020 Sep - Oct; 37:101678.TM

Authors+Show Affiliations

Internal Medicine Department, Universidad Industrial de Santander, Bucaramanga, Colombia; Faculty of Health Sciences, Universidad de Sucre, Sincelejo, Colombia. Electronic address: yeimer10@hotmail.com.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32325121

Citation

Ortiz-Martínez, Yeimer. "Tocilizumab: a New Opportunity in the Possible Therapeutic Arsenal Against COVID-19." Travel Medicine and Infectious Disease, vol. 37, 2020, p. 101678.
Ortiz-Martínez Y. Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19. Travel Med Infect Dis. 2020;37:101678.
Ortiz-Martínez, Y. (2020). Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19. Travel Medicine and Infectious Disease, 37, 101678. https://doi.org/10.1016/j.tmaid.2020.101678
Ortiz-Martínez Y. Tocilizumab: a New Opportunity in the Possible Therapeutic Arsenal Against COVID-19. Travel Med Infect Dis. 2020 Sep - Oct;37:101678. PubMed PMID: 32325121.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19. A1 - Ortiz-Martínez,Yeimer, Y1 - 2020/04/20/ PY - 2020/04/04/received PY - 2020/04/15/accepted PY - 2020/4/24/pubmed PY - 2020/10/27/medline PY - 2020/4/24/entrez KW - COVID-19 KW - Coronavirus KW - IL-6 KW - SARS-CoV-2 KW - Tocilizumab SP - 101678 EP - 101678 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 37 SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/32325121/Tocilizumab:_A_new_opportunity_in_the_possible_therapeutic_arsenal_against_COVID_19_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(20)30146-0 DB - PRIME DP - Unbound Medicine ER -